Top Clinical Trials companies in Finland by Net Cash Used For Investing Activities

This ranking features the top 2 Clinical Trials companies in Finland ranked by Net Cash Used For Investing Activities, totaling a Net Cash Used For Investing Activities of USD 76.16 K, for February 08, 2025.

Finland

Clinical Trials
Net Cash Used For Investing Activities
#
Name
Net Cash Used For Investing Activities
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
BIOBV.HE

Biohit Oyj

1

BIOBV.HE
USD 211.92 K
Dec. 31, 2023 USD 3.39 7.41%

Finland
2
FARN.L

Faron Pharmaceuticals Oy

2

FARN.L
USD -135.76 K
Dec. 31, 2023 USD 2.11 12.72%

Finland
Frequently Asked Questions
  • Which Clinical Trials company in Finland has the highest Net Cash Used For Investing Activities ?

    The Clinical Trials company in Finland with the highest Net Cash Used For Investing Activities is Biohit Oyj (Helsinki Stock Exchange: BIOBV.HE) at USD 211.92 K.

  • Which Clinical Trials company in Finland has the lowest Net Cash Used For Investing Activities ?

    The Clinical Trials company in Finland with the lowest Net Cash Used For Investing Activities is Faron Pharmaceuticals Oy (LSE: FARN.L) at USD -135.76 K.

  • What are the top 10 Clinical Trials companies in Finland by Net Cash Used For Investing Activities ?

    The top 10 Clinical Trials companies in Finland by Net Cash Used For Investing Activities are Biohit Oyj and Faron Pharmaceuticals Oy.

  • What are the bottom 10 Clinical Trials companies in Finland by Net Cash Used For Investing Activities ?

    The bottom 10 Clinical Trials companies in Finland by Net Cash Used For Investing Activities are Faron Pharmaceuticals Oy and Biohit Oyj.

SV Wall Street